SCHEMBL23463695

SCHEMBL23463695

COc1cccc(C(=O)c2ccc(C(N)=O)cc2)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.56
▸ KDM4E B2RXH2 5/20 0.56
▸ HSD17B10 Q99714 4/20 0.56
▸ ALDH1A1 P00352 4/20 0.56
▸ MAPK1 P28482 3/20 0.56
▸ ALOX15 P16050 3/20 0.56
▸ LMNA P02545 3/20 0.56
▸ CYP3A4 P08684 3/20 0.56
▸ HPGD P15428 3/20 0.56
▸ RECQL P46063 2/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ KLK1 P06870 1/20 0.54
▸ KLK5 Q9Y337 1/20 0.54
▸ STS P08842 1/20 0.49
▸ KLKB1 P03952 1/20 0.48
▸ PARP10 Q53GL7 2/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ PARP1 P09874 1/20 0.47
▸ PARP2 Q9UGN5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9339212 0.86 NPC1 (0.59) MAPTKDM4EHSD17B10ALDH1A1MAPK1
SCHEMBL1696776 0.85 MAPT (0.76) MAPTKDM4EHSD17B10ALDH1A1MAPK1
SCHEMBL1355519 0.83 ALDH1A1 (0.55) MAPTKDM4EHSD17B10ALDH1A1MAPK1
SCHEMBL480276 0.83 KDM4E (0.59) MAPTKDM4EHSD17B10ALDH1A1MAPK1
SCHEMBL9628988 0.82 MAPT (0.54) MAPTKDM4EHSD17B10ALDH1A1MAPK1
SCHEMBL22588880 0.81 KDM4E (0.57) MAPTKDM4EHSD17B10ALDH1A1MAPK1
SCHEMBL2066210 0.81 KDM4E (0.57) MAPTKDM4EHSD17B10ALDH1A1MAPK1
Acetic Acid SCHEMBL20596711 0.79 KLKB1 (0.51) MAPTKDM4EHSD17B10ALDH1A1MAPK1
SCHEMBL23463729 0.79 CYP3A4 (0.56) MAPTKDM4EHSD17B10ALDH1A1CYP3A4
SCHEMBL8746603 0.78 ALOX15 (0.56) MAPTKDM4EHSD17B10ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163444-A1 KINASE INHIBITORS FOR THE TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS UNIVERSITY OF MIAMI 2021-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163444-A1 KINASE INHIBITORS FOR THE TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS PNCK, PYGB, PMP22 MAPT 360/4885KDM4E 3853/4885HSD17B10 3287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback